Source:http://linkedlifedata.com/resource/pubmed/id/16121340
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2005-9-5
|
pubmed:databankReference | |
pubmed:abstractText |
The hormonal etiology of breast cancer is well-established. Many studies have assessed whether polymorphisms in steroid hormone metabolism genes are associated with breast cancer risk. We measured the CYP17A1 -34T>C (c.-34T>C) promoter polymorphism in a population-based study of 1,404 Australian women with breast cancer diagnosed before age 60 years (case probands), 1,903 relatives, and 788 controls. Within-family analyses suggested the CC genotype was associated with, on average, a small increased risk. This finding appeared to be influenced by the families of three early-onset case probands with multiple affected sisters. CYP17A1 mutation screening revealed a case proband diagnosed at age 38 years who had a germline protein-truncating mutation (c.775C>T, p.Arg239X), which results in a nonfunctional enzyme and has been reported in a male compound heterozygote with 17 alpha-hydroxylase deficiency. This mutation was carried by both sisters diagnosed with breast cancer at ages 34 and 42 years, but not by a 57-year-old unaffected sister. It was not found in any of the other tested case probands (48 with multiple-affected relatives and 241 randomly selected) or controls. This study suggests there may be rare mutations in steroid hormone metabolism genes associated with a high dominantly-inherited breast cancer risk, and demonstrates how "high-risk susceptibility genes" might be discovered using population-based case-control-family studies.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1098-1004
|
pubmed:author |
pubmed-author:Chenevix-TrenchGeorgiaG,
pubmed-author:DiteGillian SGS,
pubmed-author:GilesGraham GGG,
pubmed-author:HayesVanessa MVM,
pubmed-author:HopperJohn LJL,
pubmed-author:JenkinsMark AMA,
pubmed-author:McCredieMargaret R EMR,
pubmed-author:MilneRoger LRL,
pubmed-author:SoutheyMelissa CMC,
pubmed-author:SpurdleAmanda BAB,
pubmed-author:TesorieroAndrea AAA
|
pubmed:copyrightInfo |
(c) 2005 Wiley-Liss, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
298-302
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:16121340-Adult,
pubmed-meshheading:16121340-Age of Onset,
pubmed-meshheading:16121340-Breast Neoplasms,
pubmed-meshheading:16121340-Case-Control Studies,
pubmed-meshheading:16121340-Female,
pubmed-meshheading:16121340-Genetic Predisposition to Disease,
pubmed-meshheading:16121340-Humans,
pubmed-meshheading:16121340-Middle Aged,
pubmed-meshheading:16121340-Mutation,
pubmed-meshheading:16121340-Polymorphism, Genetic,
pubmed-meshheading:16121340-Population,
pubmed-meshheading:16121340-Risk Factors,
pubmed-meshheading:16121340-Siblings,
pubmed-meshheading:16121340-Steroid 17-alpha-Hydroxylase
|
pubmed:year |
2005
|
pubmed:articleTitle |
A protein-truncating mutation in CYP17A1 in three sisters with early-onset breast cancer.
|
pubmed:affiliation |
Centre for Genetic Epidemiology, The University of Melbourne, Carlton, Victoria, Australia. j.hopper@unimelb.edu.au
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|